Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma (Q62820902)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma |
clinical trial |
Statements
Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization (English)
0 references
1 May 2018
0 references
30 June 2019
0 references
22
0 references
18 year
0 references
75 year
0 references